Recombinant Human CDKN2AIP protein (ab163139)
- Datasheet
- References
- Protocols
Overview
-
Product nameRecombinant Human CDKN2AIP protein
-
Protein lengthFull length protein
Description
-
NatureRecombinant
-
SourceWheat germ
-
Amino Acid Sequence
-
SpeciesHuman
-
SequenceMAQEVSEYLSQNPRVAAWVEALRCDGETDKHWRHRRDFLLRNAGDLAPAG GAASASTDEAADAESGTRNRQLQQLISFSMAWANHVFLGCRYPQKVMDKI LSMAEGIKVTDAPTYTTRDELVAKVKKRGISSSNEGVEEPSKKRVIEGKN SSAVEQDHAKTSAKTERASAQQENSSTCIGSAIKSESGNSARSSGISSQN SSTSDGDRSVSSQSSSSVSSQVTTAGSGKASEAEAPDKHGSSFVSLLKSS VNSHMTQSTDSRQQSGSPKKSALEGSSASASQSSSEIEVPLLGSSGSSEV ELPLLSSKPSSETASSGLTSKTSSEASVSSSVAKNSSSSGTSLLTPKSSS STNTSLLTSKSTSQVAASLLASKSSSQTSGSLVSKSTSLASVSQLASKSS SQTSTSQLPSKSTSQSSESSVKFSCKLTNEDVKQKQPFFNRLYKTVAWKL VAVGGFSPNVNHGELLNAAIEALKATLDVFFVPLKELADLPQNKSSQESI VCELRCKSVYLGTGCGKSKENAKAVASREALKLFLKKKVVVKICKRKYRG SEIEDLVLLDEESRPVNLPPALKHPQELL
-
Amino acids1 to 579
-
Tagsproprietary tag N-Terminus
-
Specifications
Our Abpromise guarantee covers the use of ab163139 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
-
Applications
Western blot
ELISA
-
FormLiquid
-
Additional notesProtein concentration is above or equal to 0.05 mg/ml.
-
Concentration information loading...
Preparation and Storage
-
Stability and Storage
Shipped on dry ice. Upon delivery aliquot and store at -80ºC. Avoid freeze / thaw cycles.
pH: 8.00
Constituents: 0.31% Glutathione, 0.79% Tris HCl
General Info
-
Alternative names
- Calcium response factor
- CARF
- CARF_HUMAN
see all -
FunctionActivates p53/TP53 by CDKN2A-dependent and CDKN2A-independent pathways.
-
Tissue specificityUbiquitously expressed.
-
Sequence similaritiesBelongs to the CARF family.
Contains 1 DRBM (double-stranded RNA-binding) domain. -
Post-translational
modificationsMay be ubiquitinated. -
Cellular localizationNucleus > nucleoplasm.
- Information by UniProt
Images
Datasheets and documents
References
ab163139 has not yet been referenced specifically in any publications.